Susquehanna International Group
ONCY

Susquehanna International Group’s Oncolytics Biotech ONCY Stock Holding History

Susquehanna International Group’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.1K Buy
+41,323
New +$41.1K ﹤0.01% 12725
2025
Q2 		– Sell
-19,994
Closed -$11K – 13425
2025
Q1 		$11K Buy
+19,994
New +$14.6K ﹤0.01% 12208
2024
Q1 		– Sell
-30,306
Closed -$40.9K – 12999
2023
Q4 		$40.9K Buy
+30,306
New +$47.4K ﹤0.01% 11791
2022
Q3 		– Sell
-71,167
Closed -$70K – 13859
2022
Q2 		$70K Buy
+71,167
New +$86.5K ﹤0.01% 11770
2022
Q1 		– Sell
-10,059
Closed -$14K – 13695
2021
Q4 		$14K Buy
+10,059
New +$18.6K ﹤0.01% 12883
2019
Q2 		– Sell
-10,143
Closed -$19K – 10650
2019
Q1 		$19K Sell
10,143
-4,424
-30% -$8.96K ﹤0.01% 8597
2018
Q4 		$26K Buy
+14,567
New +$39.5K ﹤0.01% 8638

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group's ONCY Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Oncolytics Biotech (ONCY) in Q1 2026: 41,323 shares worth $35.1K. The stake represents ﹤0.01% of the portfolio and ranks #12725 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in ONCY as recently as Q1 2025.

Susquehanna International Group first reported a position in ONCY in Q4 2018 and has held it in 7 quarters since. The position peaked at $70K in Q2 2022. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

  • Susquehanna International Group held 41,323 shares of Oncolytics Biotech worth $35.1K as of Q1 2026.
  • Oncolytics Biotech was a new Susquehanna International Group position in Q1 2026.
  • Oncolytics Biotech made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12725 holding.
  • Susquehanna International Group first reported a position in Oncolytics Biotech in Q4 2018 and has held it in 7 quarters since.
  • Susquehanna International Group's Oncolytics Biotech position peaked at $70K in Q2 2022.
  • 59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.